Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial (Q37217280)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2009
edit
Language Label Description Also known as
English
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
scientific article published on June 2009

    Statements

    Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial (English)
    Tania Mara Welzel
    Timothy R Morgan
    Herbert L Bonkovsky
    Deepa Naishadham
    Elizabeth C Wright
    Amy A Hutchinson
    Andrew T Crenshaw
    Myhanh Dotrang
    Richard K Sterling
    Karen L Lindsay
    Robert J Fontana
    William M Lee
    Marc G Ghany
    David R Gretch
    Thomas R O'Brien
    HALT-C Trial Group
    1 June 2009
    1847-1858

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit